Works by San Miguel, Jesús F.

Results: 61
    1
    2
    3
    4

    Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.

    Published in:
    European Journal of Haematology, 2011, v. 86, n. 1, p. 23, doi. 10.1111/j.1600-0609.2010.01533.x
    By:
    • Dimopoulos, Meletios A.;
    • Mateos, Maria-Victoria;
    • Richardson, Paul G.;
    • Schlag, Rudolf;
    • Khuageva, Nuriet K.;
    • Shpilberg, Ofer;
    • Kropff, Martin;
    • Spicka, Ivan;
    • Palumbo, Antonio;
    • Wu, Ka Lung;
    • Esseltine, Dixie-Lee;
    • Liu, Kevin;
    • Deraedt, William;
    • Cakana, Andrew;
    • Van De Velde, Helgi;
    • San Miguel, Jesús F.
    Publication type:
    Article
    5
    6

    Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

    Published in:
    European Journal of Haematology, 2009, v. 82, n. 6, p. 426, doi. 10.1111/j.1600-0609.2009.01257.x
    By:
    • Stadtmauer, Edward A.;
    • Weber, Donna M.;
    • Niesvizky, Ruben;
    • Belch, Andrew;
    • Prince, Miles H.;
    • San Miguel, Jesús F.;
    • Facon, Thierry;
    • Olesnyckyj, Marta;
    • Yu, Zhinuan;
    • Zeldis, Jerome B.;
    • Knight, Robert D.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    7

    Medium-term results of percutaneous vertebroplasty in multiple myeloma.

    Published in:
    European Journal of Haematology, 2006, v. 77, n. 1, p. 7, doi. 10.1111/j.0902-4441.2005.t01-1-EJH2355.x
    By:
    • Ramos, Luis;
    • de las Heras, José Antonio;
    • Sánchez, Sergio;
    • González-Porras, José Ramón;
    • González, Rafael;
    • Mateos, Maria Victoria;
    • San Miguel, Jesús F.
    Publication type:
    Article
    8

    Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.

    Published in:
    Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0495-y
    By:
    • López-Iglesias, Ana-Alicia;
    • Herrero, Ana B.;
    • Chesi, Marta;
    • San-Segundo, Laura;
    • González-Méndez, Lorena;
    • Hernández-García, Susana;
    • Misiewicz-Krzeminska, Irena;
    • Quwaider, Dalia;
    • Martín-Sánchez, Montserrat;
    • Primo, Daniel;
    • Paíno, Teresa;
    • Bergsagel, P. Leif;
    • Mehrling, Thomas;
    • González-Díaz, Marcos;
    • San-Miguel, Jesús F.;
    • Mateos, María-Victoria;
    • Gutiérrez, Norma C.;
    • Garayoa, Mercedes;
    • Ocio, Enrique M.
    Publication type:
    Article
    9
    10

    Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. 700, doi. 10.1002/ajh.26507
    By:
    • Rojas, Elizabeta A.;
    • Corchete, Luis A.;
    • De Ramón, Cristina;
    • Krzeminski, Patryk;
    • Quwaider, Dalia;
    • García‐Sanz, Ramón;
    • Martínez‐López, Joaquín;
    • Oriol, Albert;
    • Rosiñol, Laura;
    • Bladé, Joan;
    • Lahuerta, Juan José;
    • San Miguel, Jesús F.;
    • González, Marcos;
    • Mateos, María Victoria;
    • Bourdon, Jean‐Christophe;
    • Misiewicz‐Krzeminska, Irena;
    • Gutiérrez, Norma C.
    Publication type:
    Article
    11

    Authors' Response.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 8, p. 146, doi. 10.1002/ajh.24079
    By:
    • Mateos, María-Victoria;
    • Shi, Hongliang;
    • San Miguel, Jesús F.
    Publication type:
    Article
    12
    13
    14

    DNA Cell Content Studies in Multiple Myeloma.

    Published in:
    Leukemia & Lymphoma, 1996, v. 23, n. 1/2, p. 33, doi. 10.3109/10428199609054799
    By:
    • Miguel, Jesús F. San;
    • GarcÍA-Sanz, RamÓN;
    • GonzÁLez, Marcos;
    • OrfÃO, Alberto
    Publication type:
    Article
    15
    16

    Expression profile of Bcl‐2 family proteins in newly diagnosed multiple myeloma patients.

    Published in:
    HemaSphere, 2024, v. 8, n. 12, p. 1, doi. 10.1002/hem3.70036
    By:
    • De Ramón, Cristina;
    • Rojas, Elizabeta A.;
    • Misiewicz‐Krzeminska, Irena;
    • Cardona‐Benavides, Ignacio J.;
    • Cuadrado, Myriam;
    • Isidro, Isabel;
    • Calasanz, María‐José;
    • Fernandez, Manuela;
    • García‐Sanz, Ramón;
    • Puig, Noemi;
    • Cedena, M. Teresa;
    • Paiva, Bruno;
    • Rosiñol, Laura;
    • Martínez‐López, Joaquín;
    • Bladé, Joan;
    • Lahuerta, Juan J.;
    • San Miguel, Jesús F.;
    • Mateos, María V.;
    • Corchete, Luis A.;
    • Gutiérrez, Norma C.
    Publication type:
    Article
    17
    18

    Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agents: analysis of the VISTA trial

    Published in:
    British Journal of Haematology, 2011, v. 153, n. 2, p. 212, doi. 10.1111/j.1365-2141.2011.08569.x
    By:
    • Richardson, Paul;
    • Schlag, Rudolf;
    • Khuageva, Nuriet;
    • Dimopoulos, Meletios;
    • Shpilberg, Ofer;
    • Kropff, Martin;
    • Vekemans, Marie-Christiane;
    • Petrucci, Maria Teresa;
    • Rossiev, Viktor;
    • Hou, Jian;
    • Robak, Tadeusz;
    • Mateos, Maria-Victoria;
    • Anderson, Kenneth;
    • Esseltine, Dixie-Lee;
    • Cakana, Andrew;
    • Liu, Kevin;
    • Deraedt, William;
    • van de Velde, Helgi;
    • San Miguel, Jesús F.
    Publication type:
    Article
    19

    Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.

    Published in:
    British Journal of Haematology, 2010, v. 148, n. 1, p. 110, doi. 10.1111/j.1365-2141.2009.07929.x
    By:
    • Pérez-Persona, Ernesto;
    • Mateo, Gema;
    • García-Sanz, Ramón;
    • Mateos, María-Victoria;
    • de las Heras, Natalia;
    • de Coca, Alfonso García;
    • Hernández, José M.;
    • Galende, Josefina;
    • Martín-Nuñez, Guillermo;
    • Bárez, Abelardo;
    • Alonso, José M.;
    • Martín, Alejandro;
    • López-Berges, Consuelo;
    • Orfao, Alberto;
    • San Miguel, Jesús F.;
    • Vidriales, María-Belén
    Publication type:
    Article
    20

    Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study.

    Published in:
    British Journal of Haematology, 2008, v. 143, n. 4, p. 511, doi. 10.1111/j.1365-2141.2008.07378.x
    By:
    • Lee, Stephanie J.;
    • Richardson, Paul G.;
    • Sonneveld, Pieter;
    • Schuster, Michael W.;
    • Irwin, David;
    • San Miguel, Jesús-F.;
    • Crawford, Bruce;
    • Massaro, Joseph;
    • Dhawan, Ravinder;
    • Gupta, Sanjay;
    • Anderson, Kenneth C.
    Publication type:
    Article
    21
    22
    23
    24

    Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft- versus-host disease after allogeneic transplantation.

    Published in:
    British Journal of Haematology, 2005, v. 130, n. 3, p. 394, doi. 10.1111/j.1365-2141.2005.05614.x
    By:
    • Pérez-Simón, José A.;
    • Díez-Campelo, María;
    • Martino, Rodrigo;
    • Brunet, Salut;
    • Urbano, Álvaro;
    • Caballero, María D.;
    • León, Ángel;
    • Valcárcel, David;
    • Carreras, Enric;
    • del Cañizo, María C.;
    • López-Fidalgo, Jesús;
    • Sierra, Jordi;
    • San Miguel, Jesús F.
    Publication type:
    Article
    25
    26
    27

    Reply to Yanamandra et al.

    Published in:
    British Journal of Haematology, 2003, v. 120, n. 6, p. 1096, doi. 10.1046/j.1365-2141.2003.04208_6.x
    By:
    • García-Sanz, Ramón;
    • González-Fraile, M. Isabel;
    • San Miguel, Jesús F.
    Publication type:
    Article
    28

    Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival.

    Published in:
    British Journal of Haematology, 2002, v. 118, n. 4, p. 1034, doi. 10.1046/j.1365-2141.2002.03749.x
    By:
    • Mateos, Maria V.;
    • García-Sanz, Ramón;
    • López-Pérez, Ricardo;
    • Moro, Maria J.;
    • Ocio, Enrique;
    • Hernández, Jose;
    • Megido, Marta;
    • Caballero, Maria D.;
    • Fernández-Calvo, Javier;
    • Bárez, Abelardo;
    • Almeida, Julia;
    • Orfão, Alberto;
    • González, Marcos;
    • San Miguel, Jesús F
    Publication type:
    Article
    29
    30
    31
    32

    The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease.

    Published in:
    British Journal of Haematology, 1999, v. 106, n. 2, p. 400, doi. 10.1046/j.1365-2141.1999.01572.x
    By:
    • Díaz-Agustín, Beatriz;
    • Escribano, Luis;
    • Bravo, Pilar;
    • Herrero, Sonia;
    • Nuñez, Rosa;
    • Navalón, Raquel;
    • Navarro, Lourdes;
    • Torrelo, Antonio;
    • Cantalapiedra, Alberto;
    • del Castillo, Luz;
    • Villarrubia, Jesús;
    • Navarro, José L.;
    • San Miguel, Jesús F.;
    • Orfao, Alberto
    Publication type:
    Article
    33

    Bortezomib is an efficient agent in plasma cell leukemias.

    Published in:
    International Journal of Cancer, 2005, v. 114, n. 4, p. 665, doi. 10.1002/ijc.20793
    By:
    • Esparís-Ogando, Azucena;
    • Alegre, Adrián;
    • Aguado, Beatriz;
    • Mateo, Gema;
    • Gutiérrez, Norma;
    • Bladé, Joan;
    • Schenkein, David;
    • Pandiella, Atanasio;
    • San Miguel, Jesús F.
    Publication type:
    Article
    34

    Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.

    Published in:
    Cancers, 2020, v. 12, n. 12, p. 3615, doi. 10.3390/cancers12123615
    By:
    • Puig, Noemí;
    • Corchete-Sánchez, Luis A.;
    • Pérez-Morán, José J.;
    • Dávila, Julio;
    • Paíno, Teresa;
    • de la Rubia, Javier;
    • Oriol, Albert;
    • Martín-Sánchez, Jesús;
    • de Arriba, Felipe;
    • Bladé, Joan;
    • Blanchard, María-Jesús;
    • González-Calle, Verónica;
    • García-Sanz, Ramón;
    • Paiva, Bruno;
    • Lahuerta, Juan-José;
    • San-Miguel, Jesús F.;
    • Mateos, María-Victoria;
    • Ocio, Enrique M.
    Publication type:
    Article
    35
    36

    The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054458
    By:
    • Villar, Sara;
    • Ariceta, Beñat;
    • Agirre, Xabier;
    • Urribarri, Aura Daniela;
    • Ayala, Rosa;
    • Martínez-Cuadrón, David;
    • Bergua, Juan Miguel;
    • Vives, Susana;
    • Algarra, Lorenzo;
    • Tormo, Mar;
    • Martínez, Pilar;
    • Serrano, Josefina;
    • Simoes, Catia;
    • Herrera, Pilar;
    • Calasanz, Maria José;
    • Alfonso-Piérola, Ana;
    • Paiva, Bruno;
    • Martínez-López, Joaquín;
    • San Miguel, Jesús F.;
    • Prósper, Felipe
    Publication type:
    Article
    37

    New Approaches to Smoldering Myeloma.

    Published in:
    Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 270, doi. 10.1007/s11899-013-0174-1
    By:
    • Mateos, María-Victoria;
    • San Miguel, Jesús F.
    Publication type:
    Article
    38

    Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.

    Published in:
    2016
    By:
    • Orlowski, Robert Z.;
    • Nagler, Arnon;
    • Sonneveld, Pieter;
    • Bladé, Joan;
    • Hajek, Roman;
    • Spencer, Andrew;
    • Robak, Tadeusz;
    • Dmoszynska, Anna;
    • Horvath, Noemi;
    • Spicka, Ivan;
    • Sutherland, Heather J.;
    • Suvorov, Alexander N.;
    • Xiu, Liang;
    • Cakana, Andrew;
    • Parekh, Trilok;
    • San‐Miguel, Jesús F.
    Publication type:
    journal article
    39
    40

    Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.

    Published in:
    Cancers, 2021, v. 13, n. 19, p. 4924, doi. 10.3390/cancers13194924
    By:
    • Puig, Noemí;
    • Flores-Montero, Juan;
    • Burgos, Leire;
    • Cedena, María-Teresa;
    • Cordón, Lourdes;
    • Pérez, José-Juan;
    • Sanoja-Flores, Luzalba;
    • Manrique, Irene;
    • Rodríguez-Otero, Paula;
    • Rosiñol, Laura;
    • Martínez-López, Joaquín;
    • Mateos, María-Victoria;
    • Lahuerta, Juan-José;
    • Bladé, Joan;
    • San Miguel, Jesús F.;
    • Orfao, Alberto;
    • Paiva, Bruno
    Publication type:
    Article
    41

    Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 522, doi. 10.1111/bjh.16788
    By:
    • Ocio, Enrique M.;
    • Motlló, Cristina;
    • Rodríguez‐Otero, Paula;
    • Martínez‐López, Joaquín;
    • Cejalvo, Mª José;
    • Martín‐Sánchez, Jesús;
    • Bladé, Joan;
    • García‐Malo, Mª Dolores;
    • Dourdil, Mª Victoria;
    • García‐Mateo, Aránzazu;
    • Arriba, Felipe;
    • García‐Sanz, Ramón;
    • Rubia, Javier;
    • Oriol, Albert;
    • Lahuerta, Juan‐José;
    • San‐Miguel, Jesús F.;
    • Mateos, María‐Victoria
    Publication type:
    Article
    42

    Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 66, doi. 10.1111/bjh.14821
    By:
    • San‐Miguel, Jesús F.;
    • Hungria, Vania T. M.;
    • Yoon, Sung‐Soo;
    • Beksac, Meral;
    • Dimopoulos, Meletios A.;
    • Elghandour, Ashraf;
    • Jedrzejczak, Wieslaw W.;
    • Guenther, Andreas;
    • Na Nakorn, Thanyaphong;
    • Siritanaratkul, Noppadol;
    • Schlossman, Robert L.;
    • Hou, Jian;
    • Moreau, Philippe;
    • Lonial, Sagar;
    • Lee, Jae‐Hoon;
    • Einsele, Hermann;
    • Salwender, Hans;
    • Sopala, Monika;
    • Redhu, Suman;
    • Paul, Sofia
    Publication type:
    Article
    43

    A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 4, p. 547, doi. 10.1111/bjh.14708
    By:
    • Laubach, Jacob P.;
    • Moslehi, Javid J.;
    • Francis, Sanjeev A.;
    • San Miguel, Jesús F.;
    • Sonneveld, Pieter;
    • Orlowski, Robert Z.;
    • Moreau, Philippe;
    • Rosiñol, Laura;
    • Faber, Edward A.;
    • Voorhees, Peter;
    • Mateos, Maria ‐ Victoria;
    • Marquez, Loreta;
    • Feng, Huaibao;
    • Desai, Avinash;
    • Velde, Helgi;
    • Elliott, Jennifer;
    • Shi, Hongliang;
    • Dow, Edward;
    • Jobanputra, Nishith;
    • Esseltine, Dixie ‐ Lee
    Publication type:
    Article
    44
    45
    46
    47

    Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects.

    Published in:
    PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034914
    By:
    • Garcia-Gomez, Antonio;
    • Ocio, Enrique M.;
    • Crusoe, Edvan;
    • Santamaria, Carlos;
    • Hernández-Campo, Pilar;
    • Blanco, Juan F.;
    • Sanchez-Guijo, Fermin M.;
    • Hernández-Iglesias, Teresa;
    • Briñón, Jesús G.;
    • Fisac-Herrero, Rosa M.;
    • Lee, Francis Y.;
    • Pandiella, Atanasio;
    • Miguel, Jesús F. San;
    • Garayoa, Mercedes
    Publication type:
    Article
    48

    Deficient Spindle Assembly Checkpoint in Multiple Myeloma.

    Published in:
    PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027583
    By:
    • Díaz-Rodríguez, Elena;
    • Álvarez-Fernández, Stela;
    • Xi Chen;
    • Paiva, Bruno;
    • López-Pérez, Ricardo;
    • García-Hernández, Juan Luis;
    • Miguel, Jesús F. San;
    • Pandiella, Atanasio
    Publication type:
    Article
    49
    50

    Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.

    Published in:
    American Journal of Hematology, 1999, v. 60, n. 3, p. 191, doi. 10.1002/(SICI)1096-8652(199903)60:3<191::AID-AJH4>3.0.CO;2-Y
    By:
    • Cerveró, Carlos;
    • Escribano, Luis;
    • San Miguel, Jesús F.;
    • Díaz-Agustín, Beatriz;
    • Bravo, Pilar;
    • Villarrubia, Jesús;
    • García-Sanz, Ramón;
    • Velasco, José L.;
    • Herrera, Pilar;
    • Vargas, Mario;
    • González, Marcos;
    • Navarro, José L.;
    • Orfao, Alberto
    Publication type:
    Article